29,000 Shares in HealthEquity, Inc. $HQY Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al

Key Points

• Virginia Retirement Systems acquired 29,000 HealthEquity shares worth approximately $2.62 million during the second quarter. Institutional investors own 99.55% of HQY’s outstanding shares.
• HealthEquity insiders sold 12,456 shares valued at about $1.26 million in the past quarter, including transactions by Director Adrian Dillon and EVP Michael Fiore under pre-arranged Rule 10b5-1 plans.
• HealthEquity exceeded quarterly earnings expectations, reporting $1.24 in EPS and $350.73 million in revenue, with revenue up 95.5% year over year. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $111.87.

VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 29,000 shares of the company's stock, valued at approximately $2,619,000.

A number of other hedge funds have also recently bought and sold shares of the company. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity during the fourth quarter worth $27,000. Caitong International Asset Management Co. Ltd boosted its holdings in HealthEquity by 1,723.5% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company's stock valued at $28,000 after acquiring an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new position in HealthEquity in the fourth quarter valued at about $28,000. Leonteq Securities AG boosted its holdings in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company's stock valued at $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC acquired a new stake in HealthEquity in the first quarter worth about $33,000. 99.55% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other HealthEquity news, Director Adrian T. Dillon sold 7,632 shares of the company's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the completion of the sale, the director owned 62,395 shares of the company's stock, valued at approximately $6,527,140.95. This represents a 10.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Fiore sold 2,354 shares of the stock in a transaction on Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the sale, the executive vice president owned 52,244 shares in the company, valued at approximately $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,456 shares of company stock worth $1,256,664 over the last quarter. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

HQY has been the topic of a number of research reports. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research report on Monday, June 1st. Royal Bank Of Canada lifted their price target on shares of HealthEquity from $100.00 to $108.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 3rd. KeyCorp reissued an "overweight" rating on shares of HealthEquity in a research note on Tuesday, May 26th. Barrington Research restated an "outperform" rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday, May 22nd. Finally, Wall Street Zen cut shares of HealthEquity from a "buy" rating to a "hold" rating in a research note on Saturday, September 5th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $111.87.

HealthEquity Trading Up 2.0%

NASDAQ HQY opened at $94.55 on Friday. The stock has a 50-day simple moving average of $99.58 and a 200 day simple moving average of $89.18. The company has a market capitalization of $7.82 billion, a PE ratio of 34.13, a P/E/G ratio of 1.46 and a beta of 0.22. The company has a current ratio of 2.99, a quick ratio of 2.99 and a debt-to-equity ratio of 0.47. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $107.62.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.05. The firm had revenue of $350.73 million for the quarter, compared to analysts' expectations of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%.The company's revenue for the quarter was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Research analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services for consumer-directed benefits and healthcare savings accounts. The company helps employers, benefits advisors and individuals manage tax-advantaged accounts, including health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), commuter benefits and other employee benefit programs.

Its offerings include account administration, payment cards, reimbursement services, benefits communication, compliance support, healthcare spending tools and investment options for eligible HSA funds.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.